Briefcases -- Medical Devices -- J & J TALCUM POWDER PRODUCTS MDL 2738 Marketing, Sales Practices and Products Liability Litigation (USDC SD of Illinois)
J & J TALCUM POWDER PRODUCTS MDL 2738 Marketing, Sales Practices and Products Liability Litigation (USDC SD of Illinois)
Johnson & Johnson, is now the defendant in Multi District Litigation No. 2738, case No. 3:16-md-02738, assigned to Judge Freda L. Wolfson, US District court, New Jersey as of October 4, 2016, where J&J is forced to defend claims that exposure to its primary name brand Johnson's Baby Powder and Shower to Shower products cause ovarian cancer. This new federal MDL runs parallel to the St. Louis Circuit Court cases against J&J which include 2016 verdicts of $72 million, $70 million and $55 million won by James Onder, Esq, of which $175 million in damages were punitive and J&J is appealing all St. Louis Circuit Court verdicts. J&J claims that there is no connection to use of its products and ovarian cancer, yet there are materials as far back as 1972 which refer to a conection between use of talc and onset of ovarian cancer, and further internal J&J communications on this subject show J&J ignored studes that reflected an increased risk of cancer during prolonged use as well as developing a strategy to avoid government regulation of its products, which the juries in the St. Louis cases recognized in awarding the larger verdicts. J&J has stated they will agressively litigate all Talc based cases, specifically while the verdicts in other venues are under appeal. It is widely accepted that J&J has withheld both scientific data and internal documents that reflect use of their talc based products are linked to ovarian cancer in women.